ATP1A4 and neoplasm: Based on the results of multivariate analysis, a genomic-clinical nomogram, including primary tumor therapy outcome, residual tumor, ATP1A2, ATP1A3, and ATP1A4, was established to predict the 1-, 3-, and 5-year OS and DSS in patients with OC (Fig. 6a, c).